AptarGroup, Inc.

AptarGroup, Inc., commonly known as Aptar, is a global leader in drug delivery and consumer product dosing, dispensing, and protection technologies. The company's mission is "to be the global leader in drug delivery, consumer product dispensing and active packaging solutions, improving lives through innovation." Headquartered in Crystal Lake, Illinois, U.S., Aptar operates with a global footprint, employing over 14,000 dedicated individuals across 20 countries.

Aptar designs and manufactures a wide array of dispensing, sealing, and active packaging solutions. Its product portfolio includes spray pumps and valves, metered-dose inhaler valves, nasal spray systems, dispensing closures, and elastomer components for injection devices. The company serves diverse end markets such as pharmaceutical, beauty, food, beverage, personal care, and home care. Aptar's business is segmented into Pharma, Beauty, and Closures, with the Pharma segment often generating a significant portion of its profits and focusing on proprietary drug delivery systems and injectable solutions.

Aptar maintains a strong market position, particularly in the pharmaceutical sector, with recent growth driven by demand in GLP-1 therapies, biologics, and systemic nasal drug delivery. In a significant leadership transition, Gael Touya, President of Aptar Pharma, was appointed President and CEO, effective September 1, 2026, succeeding Stephan B. Tanda. The company continues to focus on innovation and sustainability, having been recognized as one of America's Climate Leaders and actively developing recyclable and metal-free solutions. Aptar reported strong Q1 2026 results with reported sales increasing 11% to $982.9 million, despite flat core sales due to impacts from emergency medicine destocking.